社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
Chengstacy
IP属地：未知
+关注
帖子 · 24
帖子 · 24
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
Chengstacy
Chengstacy
·
2021-12-09
That’s a good booster for the stock!
Pfizer Says Booster Neutralized Omicron but Variant May Elude Two Doses<blockquote>辉瑞表示加强剂中和了奥密克戎病毒，但变种病毒可能无法接种两剂</blockquote>
Pfizer Inc. PFE -0.62% and BioNTech SE BNTX -3.55% said that a third dose of their Covid-19 vaccine
Pfizer Says Booster Neutralized Omicron but Variant May Elude Two Doses<blockquote>辉瑞表示加强剂中和了奥密克戎病毒，但变种病毒可能无法接种两剂</blockquote>
看
2,691
回复
1
点赞
5
编组 21备份 2
分享
举报
Chengstacy
Chengstacy
·
2021-12-03
Have to wait
Grab stock rallied 7% in premarket trading<blockquote>Grab 股价在盘前交易中上涨 7%</blockquote>
Grab stock rallied 7% in premarket trading after plunging 20% on first day of trading. After comple
Grab stock rallied 7% in premarket trading<blockquote>Grab 股价在盘前交易中上涨 7%</blockquote>
看
2,755
回复
评论
点赞
3
编组 21备份 2
分享
举报
Chengstacy
Chengstacy
·
2021-11-10
Is okay
TSMC shares fell 1.42% in premarket trading<blockquote>台积电股价盘前交易下跌1.42%</blockquote>
TSMC shares fell 1.42% in premarket trading. Taiwan Semiconductor Manufacturing Co.'s October reven
TSMC shares fell 1.42% in premarket trading<blockquote>台积电股价盘前交易下跌1.42%</blockquote>
看
2,518
回复
评论
点赞
7
编组 21备份 2
分享
举报
Chengstacy
Chengstacy
·
2021-10-02
$Taiwan Semiconductor Manufacturing(TSM)$
probably can buy in???
看
2,820
回复
2
点赞
2
编组 21备份 2
分享
举报
Chengstacy
Chengstacy
·
2021-09-07
Go go go
看
2,062
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
Chengstacy
Chengstacy
·
2021-09-03
Probably to consider buying?
看
2,222
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
Chengstacy
Chengstacy
·
2021-09-01
Why share price still dropped?
Nio shares fell more than 3% in premarket trading<blockquote>蔚来股价在盘前交易中下跌超过 3%</blockquote>
Nio shares fell more than 3% in premarket trading. NIO delivered 5,880 vehicles in August 2021, repr
Nio shares fell more than 3% in premarket trading<blockquote>蔚来股价在盘前交易中下跌超过 3%</blockquote>
看
2,199
回复
1
点赞
2
编组 21备份 2
分享
举报
Chengstacy
Chengstacy
·
2021-08-31
Wow, I missed out
看
1,939
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
Chengstacy
Chengstacy
·
2021-08-16
Can consider this?
看
1,685
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
Chengstacy
Chengstacy
·
2021-08-04
Just continue moving on…
非常抱歉，此主贴已删除
看
3,415
回复
评论
点赞
2
编组 21备份 2
分享
举报
加载更多
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3577092916321492","uuid":"3577092916321492","gmtCreate":1613999389202,"gmtModify":1627525434518,"name":"Chengstacy","pinyin":"chengstacy","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/d46f3f41d17cb95ee8d8a9e817e22983","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":2,"headSize":89,"tweetSize":24,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-4","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"明星虎友","description":"加入老虎社区2000天","bigImgUrl":"https://static.tigerbbs.com/dddf24b906c7011de2617d4fb3f76987","smallImgUrl":"https://static.tigerbbs.com/53d58ad32c97254c6f74db8b97e6ec49","grayImgUrl":"https://static.tigerbbs.com/6304700d92ad91c7a33e2e92ec32ecc1","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.08.16","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":602850568,"gmtCreate":1639008771729,"gmtModify":1639008771793,"author":{"id":"3577092916321492","authorId":"3577092916321492","name":"Chengstacy","avatar":"https://static.tigerbbs.com/d46f3f41d17cb95ee8d8a9e817e22983","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577092916321492","idStr":"3577092916321492"},"themes":[],"title":"","htmlText":"That’s a good booster for the stock! ","listText":"That’s a good booster for the stock! ","text":"That’s a good booster for the stock!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/602850568","repostId":"1141815911","repostType":4,"repost":{"id":"1141815911","kind":"news","pubTimestamp":1639007843,"share":"https://www.laohunote.com/m/news/1141815911?lang=zh_CN&edition=full","pubTime":"2021-12-09 07:57","market":"us","language":"en","title":"Pfizer Says Booster Neutralized Omicron but Variant May Elude Two Doses<blockquote>辉瑞表示加强剂中和了奥密克戎病毒，但变种病毒可能无法接种两剂</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1141815911","media":"The Wall Street Journal","summary":"Pfizer Inc. PFE -0.62% and BioNTech SE BNTX -3.55% said that a third dose of their Covid-19 vaccine ","content":"<p>Pfizer Inc. PFE -0.62% and BioNTech SE BNTX -3.55% said that a third dose of their Covid-19 vaccine neutralized the Omicron variant in lab tests but that the two-dose regimen was significantly less effective at blocking the virus.</p><p><blockquote>辉瑞公司 PFE -0.62% 和 BioNTech SE BNTX -3.55% 表示，第三剂新冠肺炎疫苗在实验室测试中中中和了奥密克戎变种，但两剂方案在阻断病毒方面的效果明显较差。</blockquote></p><p> A third dose increased antibodies 25-fold compared with two doses against the Omicron variant, the companies said. Still, two doses may prove effective in preventing severe illness from Covid-19, they said, because immune cells are able to recognize 80% of parts of the spike protein that the vaccine targets.</p><p><blockquote>两家公司表示，与针对奥密克戎变种的两剂相比，第三剂疫苗将抗体增加了 25 倍。他们说，尽管如此，两剂疫苗可能能有效预防 Covid-19 引起的严重疾病，因为免疫细胞能够识别疫苗靶向的刺突蛋白的 80% 部分。</blockquote></p><p> The results were issued in a press release by the companies, and weren’t peer reviewed and published in a scientific journal.</p><p><blockquote>研究结果由两家公司在新闻稿中发布，没有经过同行评审，也没有发表在科学期刊上。</blockquote></p><p> The findings from the companies’ early study, and one by scientists in South Africa, suggest that three doses will be needed to produce a similar immune response against Omicron as was provided by just two doses in earlier strains of the virus.</p><p><blockquote>两家公司的早期研究结果表明，需要接种三剂疫苗才能产生与早期病毒株只需接种两剂疫苗就能产生类似的针对奥密克戎病毒的免疫反应。</blockquote></p><p> It also bolsters the case for repeated and periodic boosters to maintain people’s immune defenses against an evolving Covid-19, the companies said.</p><p><blockquote>两家公司表示，这也支持了重复和定期加强剂的理由，以维持人们对不断演变的 Covid-19 的免疫防御。</blockquote></p><p> “This is very positive news that should make everyone even more motivated to get vaccinated” and get a booster, said Pfizer Chief Scientific Officer Mikael Dolsten.</p><p><blockquote>“辉瑞公司首席科学官米凯尔-多尔斯滕（Mikael Dolsten）说：”这是一个非常积极的消息，应该会让每个人都更有动力接种疫苗”并接种加强剂。</blockquote></p><p> The companies’ current vaccine will provide a strong defense against Omicron, especially if people get a booster shot, Dr. Dolsten said. The three-dose regimen, he added, could provide stopgap protection against Omicron through the winter and until a new vaccine targeted directly at the variant would be ready if needed.</p><p><blockquote>多尔斯滕博士说，这些公司目前的疫苗将为预防奥密克戎病毒提供强有力的保护，尤其是在人们注射加强针的情况下。他补充说，三剂方案可以在整个冬季提供针对奥密克戎病毒的权宜之计，直到需要时直接针对该变种的新疫苗准备就绪。</blockquote></p><p> Pfizer and BioNTech are working on an Omicron-specific vaccine that they hope to have available by March 2022 if the variant becomes widespread by then. Researchers started working on the new vaccine on Thanksgiving Day, Nov. 25, shortly after Omicron was identified.</p><p><blockquote>辉瑞和 BioNTech 正在研发一种针对奥密克戎的疫苗，如果届时该变种变得广泛传播，他们希望在 2022 年 3 月之前上市。奥密克戎被发现后不久，研究人员于11月25日感恩节开始研发新疫苗。</blockquote></p><p> The vaccine trains the immune system to fight the virus by generating immune-system soldiers known as antibodies, which attach to the virus and prevent it from replicating in healthy cells. The vaccine also produces other immune-system fighters called T cells that can kick in after infection to help target and clear the virus, preventing more serious disease.</p><p><blockquote>疫苗通过产生被称为抗体的免疫系统士兵来训练免疫系统对抗病毒，抗体附着在病毒上并阻止病毒在健康细胞中复制。该疫苗还产生其他称为T细胞的免疫系统战士，可以在感染后发挥作用，帮助靶向和清除病毒，防止更严重的疾病。</blockquote></p><p> Pfizer and BioNTech said that Omicron still appears susceptible to T cells produced by the vaccine.</p><p><blockquote>辉瑞和BioNTech表示，奥密克戎似乎仍然容易受到疫苗产生的T细胞的影响。</blockquote></p><p> Dr. Dolsten estimated there is a greater than 50% chance that Omicron becomes the dominant strain spreading in the U.S. by the spring, though it is too soon to know with certainty, he said.</p><p><blockquote>多尔斯滕博士估计，到春天，奥密克戎病毒有超过50%的可能性成为在美国传播的主要毒株，但现在确定还为时过早。</blockquote></p><p> The preliminary lab data comes from an analysis of blood samples from vaccinated patients measuring antibodies capable of neutralizing the virus causing Covid-19, including the Omicron variant. Blood samples were collected three weeks after patients received their second dose, or one month after receiving their third dose.</p><p><blockquote>初步实验室数据来自对接种疫苗的患者血液样本的分析，该分析测量了能够中和导致新冠肺炎病毒（包括奥密克戎变种）的抗体。在患者接受第二剂后三周或接受第三剂后一个月采集血液样本。</blockquote></p><p> The number of antibodies generated by a third booster shot against Omicron is similar to two doses against an older strain of the virus, the companies said.</p><p><blockquote>两家公司表示，针对奥密克戎病毒的第三次加强注射产生的抗体数量与针对较旧病毒株的两剂疫苗相似。</blockquote></p><p> “These preliminary data appear to show the Pfizer vaccine does in fact protect against Omicron, and that’s very good news,” said Philip Landrigan, director of Boston College’s Global Public Health and the Global Common Good program.</p><p><blockquote>“波士顿学院全球公共卫生和全球共同利益项目主任菲利普-兰德里根（Philip Landrigan）说：”这些初步数据似乎表明，辉瑞疫苗确实可以预防奥密克戎病，这是一个非常好的消息。</blockquote></p><p> Monica Gandhi, a professor of medicine at the University of California, San Francisco, said the results suggested two doses will protect many people from getting bad cases leading to hospitalization or death.</p><p><blockquote>加州大学旧金山分校医学教授莫妮卡·甘地表示，结果表明，两剂疫苗将保护许多人免于出现导致住院或死亡的严重病例。</blockquote></p><p> “Two doses are still effective against severe disease, whether people get boosters or not,” said Dr. Gandhi, who is recommending boosters for high-risk patients, including those with HIV. “For people who are at high risk of severe disease, it’s so important to get them boosted, but I don’t think it’s mandatory for young healthy people.”</p><p><blockquote>“甘地博士说：”无论人们是否注射加强剂，两剂疫苗对严重疾病仍然有效。“对于患重病的高危人群来说，给他们接种疫苗非常重要，但我认为对于年轻的健康人群来说，这并不是强制性的。”</blockquote></p><p> The company’s early findings come a day after scientists in South Africa reported findings from early lab tests indicating a 41-fold reduction in the Pfizer-BioNTech vaccine’s neutralization of Omicron than the original version of the virus.</p><p><blockquote>在该公司的早期发现前一天，南非的科学家报告了早期实验室测试的结果表明，辉瑞-BioNTech 疫苗对奥密克戎的中和作用比原始病毒降低了 41 倍。</blockquote></p><p> The researchers, however, found greater antibody responses against Omicron in blood taken from subjects who were fully vaccinated and had previously been infected with Covid-19.</p><p><blockquote>然而，研究人员在从完全接种疫苗且之前感染过 Covid-19 的受试者身上采集的血液中发现了针对奥密克戎病毒的更大抗体反应。</blockquote></p><p> The companies will continue to work on a variant vaccine despite the promising signs that boosting with the original shot offers good protection against Omicron, said BioNTech Chief Executive Uğur Şahin. That is because they would need to see more data on how their vaccine holds up against the new variant, including real-world effectiveness data, expected in the coming weeks.</p><p><blockquote>BioNTech 首席执行官乌古尔·沙欣 (Uğur Şahin) 表示，尽管有令人鼓舞的迹象表明，用原始疫苗加强疫苗可以很好地预防奥密克戎病毒，但两家公司仍将继续研发变体疫苗。这是因为他们需要在未来几周内看到更多关于他们的疫苗如何对抗新变种的数据，包括现实世界的有效性数据。</blockquote></p><p> “Only in combination will we understand the relevance of this data and potential protection against Omicron-mediated disease and severe disease,” he said.</p><p><blockquote>“他说：”只有结合起来，我们才能了解这些数据的相关性，以及对奥密克戎介导的疾病和严重疾病的潜在保护。</blockquote></p><p> Real-world data on vaccine effectiveness against Omicron won’t be available for at least six weeks, Dr. Şahin said, because the case numbers need to be higher before this can be measured.</p><p><blockquote>沙欣博士说，关于疫苗对奥密克戎病毒有效性的真实世界数据至少要六周才能获得，因为病例数需要更高才能衡量。</blockquote></p><p></p><p> Meanwhile, the companies are moving forward with manufacturing an Omicron-specific vaccine. The first doses, for experimental use, will be ready in January, BioNTech executives said.</p><p><blockquote>与此同时，这些公司正在推进生产奥密克戎特异性疫苗。BioNTech 高管表示，用于实验用途的第一剂疫苗将于 1 月份准备就绪。</blockquote></p><p> Omicron was first identified by scientists in South Africa last month. Since then the World Health Organization has deemed it a variant of concern. And it has since been detected around the world, including in the U.S.</p><p><blockquote>上个月，南非的科学家首次发现了奥密克戎病毒。从那时起，世界卫生组织就将其视为一种令人担忧的变体。此后，包括美国在内的世界各地都发现了这种病毒。</blockquote></p><p> Researchers have been trying to understand how contagious the new strain is, as well as how well it might be able to evade Covid-19 vaccines and whether it causes severe disease. Some preliminary reports suggest the variant is more contagious but might cause milder disease, though researchers say it is too early to know.</p><p><blockquote>研究人员一直在试图了解这种新菌株的传染性，以及它在多大程度上能够逃避新冠肺炎疫苗，以及它是否会导致严重疾病。一些初步报告表明，这种变种更具传染性，但可能会导致较轻的疾病，尽管研究人员表示现在知道还为时过早。</blockquote></p><p> Pfizer and BioNTech said they expect to make four billion vaccine doses next year, even if an Omicron-specific vaccine is required by then.</p><p><blockquote>辉瑞和 BioNTech 表示，他们预计明年将生产 40 亿剂疫苗，即使届时需要奥密克戎专用疫苗。</blockquote></p><p> Dr. Dolsten said that regardless of how widespread Omicron becomes, continued booster shots will likely be needed going forward to provide protection against Covid-19. A fourth booster dose is likely to be needed in the spring or fall of 2022, he said.</p><p><blockquote>多尔斯滕博士说，无论奥密克戎病毒变得多么普遍，未来都可能需要继续注射加强针，以提供针对新冠肺炎的保护。他说，2022 年春季或秋季可能需要第四剂加强针。</blockquote></p><p> “It’s increasingly clear you need to have a long-term perspective, with continued boosting to have strong durable immunity,” said Dr. Dolsten. “If the landscape looks similar to today, we will likely continue to boost with the current vaccine.”</p><p><blockquote>“多尔斯滕博士说：”越来越明显的是，你需要有长远的眼光，不断增强免疫力，才能拥有强大的持久免疫力。“如果情况与今天相似，我们很可能会继续使用目前的疫苗进行加强。”</blockquote></p><p> Pfizer’s shares rose 1% while BioNTech’s American depositary shares fell 0.2% in morning trading.</p><p><blockquote>辉瑞公司的股价在早盘交易中上涨了 1%，而 BioNTech 的美国存托股票下跌了 0.2%。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Says Booster Neutralized Omicron but Variant May Elude Two Doses<blockquote>辉瑞表示加强剂中和了奥密克戎病毒，但变种病毒可能无法接种两剂</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Says Booster Neutralized Omicron but Variant May Elude Two Doses<blockquote>辉瑞表示加强剂中和了奥密克戎病毒，但变种病毒可能无法接种两剂</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">The Wall Street Journal</strong><span class=\"h-time small\">2021-12-09 07:57</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Pfizer Inc. PFE -0.62% and BioNTech SE BNTX -3.55% said that a third dose of their Covid-19 vaccine neutralized the Omicron variant in lab tests but that the two-dose regimen was significantly less effective at blocking the virus.</p><p><blockquote>辉瑞公司 PFE -0.62% 和 BioNTech SE BNTX -3.55% 表示，第三剂新冠肺炎疫苗在实验室测试中中中和了奥密克戎变种，但两剂方案在阻断病毒方面的效果明显较差。</blockquote></p><p> A third dose increased antibodies 25-fold compared with two doses against the Omicron variant, the companies said. Still, two doses may prove effective in preventing severe illness from Covid-19, they said, because immune cells are able to recognize 80% of parts of the spike protein that the vaccine targets.</p><p><blockquote>两家公司表示，与针对奥密克戎变种的两剂相比，第三剂疫苗将抗体增加了 25 倍。他们说，尽管如此，两剂疫苗可能能有效预防 Covid-19 引起的严重疾病，因为免疫细胞能够识别疫苗靶向的刺突蛋白的 80% 部分。</blockquote></p><p> The results were issued in a press release by the companies, and weren’t peer reviewed and published in a scientific journal.</p><p><blockquote>研究结果由两家公司在新闻稿中发布，没有经过同行评审，也没有发表在科学期刊上。</blockquote></p><p> The findings from the companies’ early study, and one by scientists in South Africa, suggest that three doses will be needed to produce a similar immune response against Omicron as was provided by just two doses in earlier strains of the virus.</p><p><blockquote>两家公司的早期研究结果表明，需要接种三剂疫苗才能产生与早期病毒株只需接种两剂疫苗就能产生类似的针对奥密克戎病毒的免疫反应。</blockquote></p><p> It also bolsters the case for repeated and periodic boosters to maintain people’s immune defenses against an evolving Covid-19, the companies said.</p><p><blockquote>两家公司表示，这也支持了重复和定期加强剂的理由，以维持人们对不断演变的 Covid-19 的免疫防御。</blockquote></p><p> “This is very positive news that should make everyone even more motivated to get vaccinated” and get a booster, said Pfizer Chief Scientific Officer Mikael Dolsten.</p><p><blockquote>“辉瑞公司首席科学官米凯尔-多尔斯滕（Mikael Dolsten）说：”这是一个非常积极的消息，应该会让每个人都更有动力接种疫苗”并接种加强剂。</blockquote></p><p> The companies’ current vaccine will provide a strong defense against Omicron, especially if people get a booster shot, Dr. Dolsten said. The three-dose regimen, he added, could provide stopgap protection against Omicron through the winter and until a new vaccine targeted directly at the variant would be ready if needed.</p><p><blockquote>多尔斯滕博士说，这些公司目前的疫苗将为预防奥密克戎病毒提供强有力的保护，尤其是在人们注射加强针的情况下。他补充说，三剂方案可以在整个冬季提供针对奥密克戎病毒的权宜之计，直到需要时直接针对该变种的新疫苗准备就绪。</blockquote></p><p> Pfizer and BioNTech are working on an Omicron-specific vaccine that they hope to have available by March 2022 if the variant becomes widespread by then. Researchers started working on the new vaccine on Thanksgiving Day, Nov. 25, shortly after Omicron was identified.</p><p><blockquote>辉瑞和 BioNTech 正在研发一种针对奥密克戎的疫苗，如果届时该变种变得广泛传播，他们希望在 2022 年 3 月之前上市。奥密克戎被发现后不久，研究人员于11月25日感恩节开始研发新疫苗。</blockquote></p><p> The vaccine trains the immune system to fight the virus by generating immune-system soldiers known as antibodies, which attach to the virus and prevent it from replicating in healthy cells. The vaccine also produces other immune-system fighters called T cells that can kick in after infection to help target and clear the virus, preventing more serious disease.</p><p><blockquote>疫苗通过产生被称为抗体的免疫系统士兵来训练免疫系统对抗病毒，抗体附着在病毒上并阻止病毒在健康细胞中复制。该疫苗还产生其他称为T细胞的免疫系统战士，可以在感染后发挥作用，帮助靶向和清除病毒，防止更严重的疾病。</blockquote></p><p> Pfizer and BioNTech said that Omicron still appears susceptible to T cells produced by the vaccine.</p><p><blockquote>辉瑞和BioNTech表示，奥密克戎似乎仍然容易受到疫苗产生的T细胞的影响。</blockquote></p><p> Dr. Dolsten estimated there is a greater than 50% chance that Omicron becomes the dominant strain spreading in the U.S. by the spring, though it is too soon to know with certainty, he said.</p><p><blockquote>多尔斯滕博士估计，到春天，奥密克戎病毒有超过50%的可能性成为在美国传播的主要毒株，但现在确定还为时过早。</blockquote></p><p> The preliminary lab data comes from an analysis of blood samples from vaccinated patients measuring antibodies capable of neutralizing the virus causing Covid-19, including the Omicron variant. Blood samples were collected three weeks after patients received their second dose, or one month after receiving their third dose.</p><p><blockquote>初步实验室数据来自对接种疫苗的患者血液样本的分析，该分析测量了能够中和导致新冠肺炎病毒（包括奥密克戎变种）的抗体。在患者接受第二剂后三周或接受第三剂后一个月采集血液样本。</blockquote></p><p> The number of antibodies generated by a third booster shot against Omicron is similar to two doses against an older strain of the virus, the companies said.</p><p><blockquote>两家公司表示，针对奥密克戎病毒的第三次加强注射产生的抗体数量与针对较旧病毒株的两剂疫苗相似。</blockquote></p><p> “These preliminary data appear to show the Pfizer vaccine does in fact protect against Omicron, and that’s very good news,” said Philip Landrigan, director of Boston College’s Global Public Health and the Global Common Good program.</p><p><blockquote>“波士顿学院全球公共卫生和全球共同利益项目主任菲利普-兰德里根（Philip Landrigan）说：”这些初步数据似乎表明，辉瑞疫苗确实可以预防奥密克戎病，这是一个非常好的消息。</blockquote></p><p> Monica Gandhi, a professor of medicine at the University of California, San Francisco, said the results suggested two doses will protect many people from getting bad cases leading to hospitalization or death.</p><p><blockquote>加州大学旧金山分校医学教授莫妮卡·甘地表示，结果表明，两剂疫苗将保护许多人免于出现导致住院或死亡的严重病例。</blockquote></p><p> “Two doses are still effective against severe disease, whether people get boosters or not,” said Dr. Gandhi, who is recommending boosters for high-risk patients, including those with HIV. “For people who are at high risk of severe disease, it’s so important to get them boosted, but I don’t think it’s mandatory for young healthy people.”</p><p><blockquote>“甘地博士说：”无论人们是否注射加强剂，两剂疫苗对严重疾病仍然有效。“对于患重病的高危人群来说，给他们接种疫苗非常重要，但我认为对于年轻的健康人群来说，这并不是强制性的。”</blockquote></p><p> The company’s early findings come a day after scientists in South Africa reported findings from early lab tests indicating a 41-fold reduction in the Pfizer-BioNTech vaccine’s neutralization of Omicron than the original version of the virus.</p><p><blockquote>在该公司的早期发现前一天，南非的科学家报告了早期实验室测试的结果表明，辉瑞-BioNTech 疫苗对奥密克戎的中和作用比原始病毒降低了 41 倍。</blockquote></p><p> The researchers, however, found greater antibody responses against Omicron in blood taken from subjects who were fully vaccinated and had previously been infected with Covid-19.</p><p><blockquote>然而，研究人员在从完全接种疫苗且之前感染过 Covid-19 的受试者身上采集的血液中发现了针对奥密克戎病毒的更大抗体反应。</blockquote></p><p> The companies will continue to work on a variant vaccine despite the promising signs that boosting with the original shot offers good protection against Omicron, said BioNTech Chief Executive Uğur Şahin. That is because they would need to see more data on how their vaccine holds up against the new variant, including real-world effectiveness data, expected in the coming weeks.</p><p><blockquote>BioNTech 首席执行官乌古尔·沙欣 (Uğur Şahin) 表示，尽管有令人鼓舞的迹象表明，用原始疫苗加强疫苗可以很好地预防奥密克戎病毒，但两家公司仍将继续研发变体疫苗。这是因为他们需要在未来几周内看到更多关于他们的疫苗如何对抗新变种的数据，包括现实世界的有效性数据。</blockquote></p><p> “Only in combination will we understand the relevance of this data and potential protection against Omicron-mediated disease and severe disease,” he said.</p><p><blockquote>“他说：”只有结合起来，我们才能了解这些数据的相关性，以及对奥密克戎介导的疾病和严重疾病的潜在保护。</blockquote></p><p> Real-world data on vaccine effectiveness against Omicron won’t be available for at least six weeks, Dr. Şahin said, because the case numbers need to be higher before this can be measured.</p><p><blockquote>沙欣博士说，关于疫苗对奥密克戎病毒有效性的真实世界数据至少要六周才能获得，因为病例数需要更高才能衡量。</blockquote></p><p></p><p> Meanwhile, the companies are moving forward with manufacturing an Omicron-specific vaccine. The first doses, for experimental use, will be ready in January, BioNTech executives said.</p><p><blockquote>与此同时，这些公司正在推进生产奥密克戎特异性疫苗。BioNTech 高管表示，用于实验用途的第一剂疫苗将于 1 月份准备就绪。</blockquote></p><p> Omicron was first identified by scientists in South Africa last month. Since then the World Health Organization has deemed it a variant of concern. And it has since been detected around the world, including in the U.S.</p><p><blockquote>上个月，南非的科学家首次发现了奥密克戎病毒。从那时起，世界卫生组织就将其视为一种令人担忧的变体。此后，包括美国在内的世界各地都发现了这种病毒。</blockquote></p><p> Researchers have been trying to understand how contagious the new strain is, as well as how well it might be able to evade Covid-19 vaccines and whether it causes severe disease. Some preliminary reports suggest the variant is more contagious but might cause milder disease, though researchers say it is too early to know.</p><p><blockquote>研究人员一直在试图了解这种新菌株的传染性，以及它在多大程度上能够逃避新冠肺炎疫苗，以及它是否会导致严重疾病。一些初步报告表明，这种变种更具传染性，但可能会导致较轻的疾病，尽管研究人员表示现在知道还为时过早。</blockquote></p><p> Pfizer and BioNTech said they expect to make four billion vaccine doses next year, even if an Omicron-specific vaccine is required by then.</p><p><blockquote>辉瑞和 BioNTech 表示，他们预计明年将生产 40 亿剂疫苗，即使届时需要奥密克戎专用疫苗。</blockquote></p><p> Dr. Dolsten said that regardless of how widespread Omicron becomes, continued booster shots will likely be needed going forward to provide protection against Covid-19. A fourth booster dose is likely to be needed in the spring or fall of 2022, he said.</p><p><blockquote>多尔斯滕博士说，无论奥密克戎病毒变得多么普遍，未来都可能需要继续注射加强针，以提供针对新冠肺炎的保护。他说，2022 年春季或秋季可能需要第四剂加强针。</blockquote></p><p> “It’s increasingly clear you need to have a long-term perspective, with continued boosting to have strong durable immunity,” said Dr. Dolsten. “If the landscape looks similar to today, we will likely continue to boost with the current vaccine.”</p><p><blockquote>“多尔斯滕博士说：”越来越明显的是，你需要有长远的眼光，不断增强免疫力，才能拥有强大的持久免疫力。“如果情况与今天相似，我们很可能会继续使用目前的疫苗进行加强。”</blockquote></p><p> Pfizer’s shares rose 1% while BioNTech’s American depositary shares fell 0.2% in morning trading.</p><p><blockquote>辉瑞公司的股价在早盘交易中上涨了 1%，而 BioNTech 的美国存托股票下跌了 0.2%。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.wsj.com/articles/pfizer-biontech-covid-19-vaccine-loses-significant-effectiveness-against-omicron-in-early-study-companies-say-11638964121?mod=hp_lead_pos1\">The Wall Street Journal</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","PFE":"辉瑞"},"source_url":"https://www.wsj.com/articles/pfizer-biontech-covid-19-vaccine-loses-significant-effectiveness-against-omicron-in-early-study-companies-say-11638964121?mod=hp_lead_pos1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1141815911","content_text":"Pfizer Inc. PFE -0.62% and BioNTech SE BNTX -3.55% said that a third dose of their Covid-19 vaccine neutralized the Omicron variant in lab tests but that the two-dose regimen was significantly less effective at blocking the virus.\n\nA third dose increased antibodies 25-fold compared with two doses against the Omicron variant, the companies said. Still, two doses may prove effective in preventing severe illness from Covid-19, they said, because immune cells are able to recognize 80% of parts of the spike protein that the vaccine targets.\n\nThe results were issued in a press release by the companies, and weren’t peer reviewed and published in a scientific journal.\n\nThe findings from the companies’ early study, and one by scientists in South Africa, suggest that three doses will be needed to produce a similar immune response against Omicron as was provided by just two doses in earlier strains of the virus.\n\n\nIt also bolsters the case for repeated and periodic boosters to maintain people’s immune defenses against an evolving Covid-19, the companies said.\n\n“This is very positive news that should make everyone even more motivated to get vaccinated” and get a booster, said Pfizer Chief Scientific Officer Mikael Dolsten.\n\nThe companies’ current vaccine will provide a strong defense against Omicron, especially if people get a booster shot, Dr. Dolsten said. The three-dose regimen, he added, could provide stopgap protection against Omicron through the winter and until a new vaccine targeted directly at the variant would be ready if needed.\n\nPfizer and BioNTech are working on an Omicron-specific vaccine that they hope to have available by March 2022 if the variant becomes widespread by then. Researchers started working on the new vaccine on Thanksgiving Day, Nov. 25, shortly after Omicron was identified.\n\nThe vaccine trains the immune system to fight the virus by generating immune-system soldiers known as antibodies, which attach to the virus and prevent it from replicating in healthy cells. The vaccine also produces other immune-system fighters called T cells that can kick in after infection to help target and clear the virus, preventing more serious disease.\n\nPfizer and BioNTech said that Omicron still appears susceptible to T cells produced by the vaccine.\n\nDr. Dolsten estimated there is a greater than 50% chance that Omicron becomes the dominant strain spreading in the U.S. by the spring, though it is too soon to know with certainty, he said.\n\nThe preliminary lab data comes from an analysis of blood samples from vaccinated patients measuring antibodies capable of neutralizing the virus causing Covid-19, including the Omicron variant. Blood samples were collected three weeks after patients received their second dose, or one month after receiving their third dose.\n\nThe number of antibodies generated by a third booster shot against Omicron is similar to two doses against an older strain of the virus, the companies said.\n\n“These preliminary data appear to show the Pfizer vaccine does in fact protect against Omicron, and that’s very good news,” said Philip Landrigan, director of Boston College’s Global Public Health and the Global Common Good program.\n\n\nMonica Gandhi, a professor of medicine at the University of California, San Francisco, said the results suggested two doses will protect many people from getting bad cases leading to hospitalization or death.\n\n“Two doses are still effective against severe disease, whether people get boosters or not,” said Dr. Gandhi, who is recommending boosters for high-risk patients, including those with HIV. “For people who are at high risk of severe disease, it’s so important to get them boosted, but I don’t think it’s mandatory for young healthy people.”\n\nThe company’s early findings come a day after scientists in South Africa reported findings from early lab tests indicating a 41-fold reduction in the Pfizer-BioNTech vaccine’s neutralization of Omicron than the original version of the virus.\n\n\n\nThe researchers, however, found greater antibody responses against Omicron in blood taken from subjects who were fully vaccinated and had previously been infected with Covid-19.\n\nThe companies will continue to work on a variant vaccine despite the promising signs that boosting with the original shot offers good protection against Omicron, said BioNTech Chief Executive Uğur Şahin. That is because they would need to see more data on how their vaccine holds up against the new variant, including real-world effectiveness data, expected in the coming weeks.\n\n\n“Only in combination will we understand the relevance of this data and potential protection against Omicron-mediated disease and severe disease,” he said.\n\nReal-world data on vaccine effectiveness against Omicron won’t be available for at least six weeks, Dr. Şahin said, because the case numbers need to be higher before this can be measured.\n\nMeanwhile, the companies are moving forward with manufacturing an Omicron-specific vaccine. The first doses, for experimental use, will be ready in January, BioNTech executives said.\n\nOmicron was first identified by scientists in South Africa last month. Since then the World Health Organization has deemed it a variant of concern. And it has since been detected around the world, including in the U.S.\n\nResearchers have been trying to understand how contagious the new strain is, as well as how well it might be able to evade Covid-19 vaccines and whether it causes severe disease. Some preliminary reports suggest the variant is more contagious but might cause milder disease, though researchers say it is too early to know.\n\nPfizer and BioNTech said they expect to make four billion vaccine doses next year, even if an Omicron-specific vaccine is required by then.\n\nDr. Dolsten said that regardless of how widespread Omicron becomes, continued booster shots will likely be needed going forward to provide protection against Covid-19. A fourth booster dose is likely to be needed in the spring or fall of 2022, he said.\n\n“It’s increasingly clear you need to have a long-term perspective, with continued boosting to have strong durable immunity,” said Dr. Dolsten. “If the landscape looks similar to today, we will likely continue to boost with the current vaccine.”\n\nPfizer’s shares rose 1% while BioNTech’s American depositary shares fell 0.2% in morning trading.","news_type":1,"symbols_score_info":{"PFE":0.9,"BNTX":0.9}},"isVote":1,"tweetType":1,"viewCount":2691,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":601685261,"gmtCreate":1638522914321,"gmtModify":1638522914321,"author":{"id":"3577092916321492","authorId":"3577092916321492","name":"Chengstacy","avatar":"https://static.tigerbbs.com/d46f3f41d17cb95ee8d8a9e817e22983","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577092916321492","idStr":"3577092916321492"},"themes":[],"title":"","htmlText":"Have to wait ","listText":"Have to wait ","text":"Have to wait","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/601685261","repostId":"1166348149","repostType":2,"repost":{"id":"1166348149","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638522212,"share":"https://www.laohunote.com/m/news/1166348149?lang=zh_CN&edition=full","pubTime":"2021-12-03 17:03","market":"us","language":"en","title":"Grab stock rallied 7% in premarket trading<blockquote>Grab 股价在盘前交易中上涨 7%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1166348149","media":"Tiger Newspress","summary":"Grab stock rallied 7% in premarket trading after plunging 20% on first day of trading.\n\nAfter comple","content":"<p>Grab stock rallied 7% in premarket trading after plunging 20% on first day of trading.</p><p><blockquote>Grab 股票在首日交易暴跌 20% 后，在盘前交易中上涨 7%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/f1ecbac0018debb2d6e75a60d1c7f3d1\" tg-width=\"853\" tg-height=\"619\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> After completing the richest deal yet for a special-purpose acquisition company,Grab Holdings Ltd. shares experienced an initial pop Thursday, their first day of trading in the U.S., but then slumped to a decline of more than 20%.</p><p><blockquote>在完成特殊目的收购公司Grab Holdings Ltd.迄今为止最富有的交易后。周四，也就是它们在美国交易的第一天，股市经历了最初的上涨，但随后暴跌至跌幅超过 20%。</blockquote></p><p> The Singapore-based company makes a \"superapp\" offering ride-hailing, delivery and financial services in more than 400 cities in Southeast Asia. Grab's chief financial officer, Peter Oey, said in an interview on Thursday that the company had its \"roughest patch\" in the third quarter ended Sept. 30 because of COVID-19-related shutdowns in Southeast Asia, especially Vietnam. But he pointed to continued expected growth and recovery, even as the company watches what happens with the new coronavirus variant, omicron.</p><p><blockquote>这家总部位于新加坡的公司开发了一款“超级应用”，在东南亚 400 多个城市提供打车、送货和金融服务。Grab 首席财务官 Peter Oey 周四在接受采访时表示，由于东南亚（尤其是越南）与 COVID-19 相关的停工，该公司在截至 9 月 30 日的第三季度经历了“最艰难的时期”。但他指出，尽管该公司正在关注新型冠状病毒变种奥密克戎的情况，但预计仍将继续增长和复苏。</blockquote></p><p> Backers of Grab, which was founded in 2012, include Didi Global Inc, Toyota Motor Corp. and SoftBank Group Corp.'s Vision Fund.</p><p><blockquote>Grab 成立于 2012 年，其支持者包括滴滴全球公司、丰田汽车公司和软银集团公司的愿景基金。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Grab stock rallied 7% in premarket trading<blockquote>Grab 股价在盘前交易中上涨 7%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGrab stock rallied 7% in premarket trading<blockquote>Grab 股价在盘前交易中上涨 7%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-03 17:03</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Grab stock rallied 7% in premarket trading after plunging 20% on first day of trading.</p><p><blockquote>Grab 股票在首日交易暴跌 20% 后，在盘前交易中上涨 7%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/f1ecbac0018debb2d6e75a60d1c7f3d1\" tg-width=\"853\" tg-height=\"619\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> After completing the richest deal yet for a special-purpose acquisition company,Grab Holdings Ltd. shares experienced an initial pop Thursday, their first day of trading in the U.S., but then slumped to a decline of more than 20%.</p><p><blockquote>在完成特殊目的收购公司Grab Holdings Ltd.迄今为止最富有的交易后。周四，也就是它们在美国交易的第一天，股市经历了最初的上涨，但随后暴跌至跌幅超过 20%。</blockquote></p><p> The Singapore-based company makes a \"superapp\" offering ride-hailing, delivery and financial services in more than 400 cities in Southeast Asia. Grab's chief financial officer, Peter Oey, said in an interview on Thursday that the company had its \"roughest patch\" in the third quarter ended Sept. 30 because of COVID-19-related shutdowns in Southeast Asia, especially Vietnam. But he pointed to continued expected growth and recovery, even as the company watches what happens with the new coronavirus variant, omicron.</p><p><blockquote>这家总部位于新加坡的公司开发了一款“超级应用”，在东南亚 400 多个城市提供打车、送货和金融服务。Grab 首席财务官 Peter Oey 周四在接受采访时表示，由于东南亚（尤其是越南）与 COVID-19 相关的停工，该公司在截至 9 月 30 日的第三季度经历了“最艰难的时期”。但他指出，尽管该公司正在关注新型冠状病毒变种奥密克戎的情况，但预计仍将继续增长和复苏。</blockquote></p><p> Backers of Grab, which was founded in 2012, include Didi Global Inc, Toyota Motor Corp. and SoftBank Group Corp.'s Vision Fund.</p><p><blockquote>Grab 成立于 2012 年，其支持者包括滴滴全球公司、丰田汽车公司和软银集团公司的愿景基金。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GRAB":"Grab Holdings"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1166348149","content_text":"Grab stock rallied 7% in premarket trading after plunging 20% on first day of trading.\n\nAfter completing the richest deal yet for a special-purpose acquisition company,Grab Holdings Ltd. shares experienced an initial pop Thursday, their first day of trading in the U.S., but then slumped to a decline of more than 20%.\nThe Singapore-based company makes a \"superapp\" offering ride-hailing, delivery and financial services in more than 400 cities in Southeast Asia. Grab's chief financial officer, Peter Oey, said in an interview on Thursday that the company had its \"roughest patch\" in the third quarter ended Sept. 30 because of COVID-19-related shutdowns in Southeast Asia, especially Vietnam. But he pointed to continued expected growth and recovery, even as the company watches what happens with the new coronavirus variant, omicron.\nBackers of Grab, which was founded in 2012, include Didi Global Inc, Toyota Motor Corp. and SoftBank Group Corp.'s Vision Fund.","news_type":1,"symbols_score_info":{"GRAB":0.9}},"isVote":1,"tweetType":1,"viewCount":2755,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":847414418,"gmtCreate":1636544818362,"gmtModify":1636545005084,"author":{"id":"3577092916321492","authorId":"3577092916321492","name":"Chengstacy","avatar":"https://static.tigerbbs.com/d46f3f41d17cb95ee8d8a9e817e22983","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577092916321492","idStr":"3577092916321492"},"themes":[],"title":"","htmlText":"Is okay","listText":"Is okay","text":"Is okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/847414418","repostId":"1154623739","repostType":2,"repost":{"id":"1154623739","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1636544529,"share":"https://www.laohunote.com/m/news/1154623739?lang=zh_CN&edition=full","pubTime":"2021-11-10 19:42","market":"us","language":"en","title":"TSMC shares fell 1.42% in premarket trading<blockquote>台积电股价盘前交易下跌1.42%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1154623739","media":"Tiger Newspress","summary":"TSMC shares fell 1.42% in premarket trading.\n\nTaiwan Semiconductor Manufacturing Co.'s October reven","content":"<p>TSMC shares fell 1.42% in premarket trading.</p><p><blockquote>台积电股价在盘前交易中下跌1.42%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/925cf65fc3c3ace443ec6883f6b03c59\" tg-width=\"878\" tg-height=\"612\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> Taiwan Semiconductor Manufacturing Co.'s October revenue was up 12.8% Y/Y to NT$134.54B or about $4.86B.</p><p><blockquote>台积电公司 10 月份营收同比增长 12.8%，达到 134.54B 新台币，约合 4.86B 美元。</blockquote></p><p> The sales were down 11.9% compared to September 2021.</p><p><blockquote>与2021年9月相比，销售额下降了11.9%。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>TSMC shares fell 1.42% in premarket trading<blockquote>台积电股价盘前交易下跌1.42%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTSMC shares fell 1.42% in premarket trading<blockquote>台积电股价盘前交易下跌1.42%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-11-10 19:42</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>TSMC shares fell 1.42% in premarket trading.</p><p><blockquote>台积电股价在盘前交易中下跌1.42%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/925cf65fc3c3ace443ec6883f6b03c59\" tg-width=\"878\" tg-height=\"612\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> Taiwan Semiconductor Manufacturing Co.'s October revenue was up 12.8% Y/Y to NT$134.54B or about $4.86B.</p><p><blockquote>台积电公司 10 月份营收同比增长 12.8%，达到 134.54B 新台币，约合 4.86B 美元。</blockquote></p><p> The sales were down 11.9% compared to September 2021.</p><p><blockquote>与2021年9月相比，销售额下降了11.9%。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSM":"台积电"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154623739","content_text":"TSMC shares fell 1.42% in premarket trading.\n\nTaiwan Semiconductor Manufacturing Co.'s October revenue was up 12.8% Y/Y to NT$134.54B or about $4.86B.\nThe sales were down 11.9% compared to September 2021.","news_type":1,"symbols_score_info":{"TSM":0.9}},"isVote":1,"tweetType":1,"viewCount":2518,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":867996514,"gmtCreate":1633181813587,"gmtModify":1633181813709,"author":{"id":"3577092916321492","authorId":"3577092916321492","name":"Chengstacy","avatar":"https://static.tigerbbs.com/d46f3f41d17cb95ee8d8a9e817e22983","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577092916321492","idStr":"3577092916321492"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/TSM\">$Taiwan Semiconductor Manufacturing(TSM)$</a>probably can buy in???","listText":"<a href=\"https://laohu8.com/S/TSM\">$Taiwan Semiconductor Manufacturing(TSM)$</a>probably can buy in???","text":"$Taiwan Semiconductor Manufacturing(TSM)$probably can buy in???","images":[{"img":"https://static.tigerbbs.com/94f11a77b9ffa683e3abe684d1a9f91e","width":"1125","height":"3060"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/867996514","isVote":1,"tweetType":1,"viewCount":2820,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":880385329,"gmtCreate":1631020560961,"gmtModify":1632904563174,"author":{"id":"3577092916321492","authorId":"3577092916321492","name":"Chengstacy","avatar":"https://static.tigerbbs.com/d46f3f41d17cb95ee8d8a9e817e22983","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577092916321492","idStr":"3577092916321492"},"themes":[],"title":"","htmlText":"Go go go","listText":"Go go go","text":"Go go go","images":[{"img":"https://static.tigerbbs.com/db9fb0976fa6b714ed431086a47a2b63","width":"1125","height":"2800"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/880385329","isVote":1,"tweetType":1,"viewCount":2062,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":815226541,"gmtCreate":1630681937583,"gmtModify":1632467163327,"author":{"id":"3577092916321492","authorId":"3577092916321492","name":"Chengstacy","avatar":"https://static.tigerbbs.com/d46f3f41d17cb95ee8d8a9e817e22983","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577092916321492","idStr":"3577092916321492"},"themes":[],"title":"","htmlText":"Probably to consider buying?","listText":"Probably to consider buying?","text":"Probably to consider buying?","images":[{"img":"https://static.tigerbbs.com/416df93e797d15183d73714693fb4c9c","width":"1125","height":"2699"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/815226541","isVote":1,"tweetType":1,"viewCount":2222,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":816829228,"gmtCreate":1630488380864,"gmtModify":1633677715152,"author":{"id":"3577092916321492","authorId":"3577092916321492","name":"Chengstacy","avatar":"https://static.tigerbbs.com/d46f3f41d17cb95ee8d8a9e817e22983","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577092916321492","idStr":"3577092916321492"},"themes":[],"title":"","htmlText":"Why share price still dropped?","listText":"Why share price still dropped?","text":"Why share price still dropped?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/816829228","repostId":"1156393470","repostType":4,"repost":{"id":"1156393470","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1630487935,"share":"https://www.laohunote.com/m/news/1156393470?lang=zh_CN&edition=full","pubTime":"2021-09-01 17:18","market":"us","language":"en","title":"Nio shares fell more than 3% in premarket trading<blockquote>蔚来股价在盘前交易中下跌超过 3%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1156393470","media":"Tiger Newspress","summary":"Nio shares fell more than 3% in premarket trading.\nNIO delivered 5,880 vehicles in August 2021, repr","content":"<p>Nio shares fell more than 3% in premarket trading.</p><p><blockquote>蔚来股价在盘前交易中下跌超过3%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/ad3301f3aa8ef1b7317bcb49d24c38de\" tg-width=\"898\" tg-height=\"627\" width=\"100%\" height=\"auto\">NIO delivered 5,880 vehicles in August 2021, representing a 48.3% year-over-year growth. While the Company’s new order reached an all-time high in August driven by the increasing demand, the vehicle production, especially the manufacturing of the ES6 and EC6, was materially disrupted by supply chain constraints resulting from the COVID-19 pandemic in certain areas in China and Malaysia. The deliveries consisted of 1,738 ES8s, the Company’s six-seater or seven-seater flagship premium smart electric SUV, 2,342 ES6s, the Company’s five-seater high-performance premium smart electric SUV, and 1,800 EC6s, the Company’s five-seater premium smart electric coupe SUV. As of August 31, 2021, cumulative deliveries of the ES8, ES6 and EC6 reached 131,408 vehicles.</p><p><blockquote>2021年8月，蔚来交付了5,880辆汽车，同比增长48.3%。虽然在需求不断增长的推动下，该公司的新订单在 8 月份创下历史新高，但由于 COVID-19 大流行在中国和马来西亚某些地区造成的供应链限制，汽车生产，尤其是 ES6 和 EC6 的生产受到了严重干扰。交付的车辆包括 1738 辆 ES8（该公司的六座或七座旗舰高端智能电动 SUV）、2342 辆 ES6（该公司的五座高性能高端智能电动 SUV）和 1800 辆 EC6（该公司的五座高端智能电动轿跑车 SUV）。截至2021年8月31日，ES8、ES6和EC6的累计交付量达到131,408辆。</blockquote></p><p> In light of the continued uncertainty and volatility of semiconductor supply, the Company prudently adjusts the vehicle production and expects to deliver approximately 22,500 to 23,500 vehicles in the third quarter of 2021, revised from the previous outlook of 23,000 to 25,000 vehicles.</p><p><blockquote>鉴于半导体供应的持续不确定性和波动性，本公司谨慎调整整车产量，预计2021年第三季度交付约22,500辆至23,500辆汽车，较之前的23,000辆至25,000辆的展望有所修正。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nio shares fell more than 3% in premarket trading<blockquote>蔚来股价在盘前交易中下跌超过 3%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNio shares fell more than 3% in premarket trading<blockquote>蔚来股价在盘前交易中下跌超过 3%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-09-01 17:18</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Nio shares fell more than 3% in premarket trading.</p><p><blockquote>蔚来股价在盘前交易中下跌超过3%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/ad3301f3aa8ef1b7317bcb49d24c38de\" tg-width=\"898\" tg-height=\"627\" width=\"100%\" height=\"auto\">NIO delivered 5,880 vehicles in August 2021, representing a 48.3% year-over-year growth. While the Company’s new order reached an all-time high in August driven by the increasing demand, the vehicle production, especially the manufacturing of the ES6 and EC6, was materially disrupted by supply chain constraints resulting from the COVID-19 pandemic in certain areas in China and Malaysia. The deliveries consisted of 1,738 ES8s, the Company’s six-seater or seven-seater flagship premium smart electric SUV, 2,342 ES6s, the Company’s five-seater high-performance premium smart electric SUV, and 1,800 EC6s, the Company’s five-seater premium smart electric coupe SUV. As of August 31, 2021, cumulative deliveries of the ES8, ES6 and EC6 reached 131,408 vehicles.</p><p><blockquote>2021年8月，蔚来交付了5,880辆汽车，同比增长48.3%。虽然在需求不断增长的推动下，该公司的新订单在 8 月份创下历史新高，但由于 COVID-19 大流行在中国和马来西亚某些地区造成的供应链限制，汽车生产，尤其是 ES6 和 EC6 的生产受到了严重干扰。交付的车辆包括 1738 辆 ES8（该公司的六座或七座旗舰高端智能电动 SUV）、2342 辆 ES6（该公司的五座高性能高端智能电动 SUV）和 1800 辆 EC6（该公司的五座高端智能电动轿跑车 SUV）。截至2021年8月31日，ES8、ES6和EC6的累计交付量达到131,408辆。</blockquote></p><p> In light of the continued uncertainty and volatility of semiconductor supply, the Company prudently adjusts the vehicle production and expects to deliver approximately 22,500 to 23,500 vehicles in the third quarter of 2021, revised from the previous outlook of 23,000 to 25,000 vehicles.</p><p><blockquote>鉴于半导体供应的持续不确定性和波动性，本公司谨慎调整整车产量，预计2021年第三季度交付约22,500辆至23,500辆汽车，较之前的23,000辆至25,000辆的展望有所修正。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NIO":"蔚来"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1156393470","content_text":"Nio shares fell more than 3% in premarket trading.\nNIO delivered 5,880 vehicles in August 2021, representing a 48.3% year-over-year growth. While the Company’s new order reached an all-time high in August driven by the increasing demand, the vehicle production, especially the manufacturing of the ES6 and EC6, was materially disrupted by supply chain constraints resulting from the COVID-19 pandemic in certain areas in China and Malaysia. The deliveries consisted of 1,738 ES8s, the Company’s six-seater or seven-seater flagship premium smart electric SUV, 2,342 ES6s, the Company’s five-seater high-performance premium smart electric SUV, and 1,800 EC6s, the Company’s five-seater premium smart electric coupe SUV. As of August 31, 2021, cumulative deliveries of the ES8, ES6 and EC6 reached 131,408 vehicles.\nIn light of the continued uncertainty and volatility of semiconductor supply, the Company prudently adjusts the vehicle production and expects to deliver approximately 22,500 to 23,500 vehicles in the third quarter of 2021, revised from the previous outlook of 23,000 to 25,000 vehicles.","news_type":1,"symbols_score_info":{"NIO":0.9}},"isVote":1,"tweetType":1,"viewCount":2199,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":818351914,"gmtCreate":1630378289838,"gmtModify":1704959390961,"author":{"id":"3577092916321492","authorId":"3577092916321492","name":"Chengstacy","avatar":"https://static.tigerbbs.com/d46f3f41d17cb95ee8d8a9e817e22983","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577092916321492","idStr":"3577092916321492"},"themes":[],"title":"","htmlText":"Wow, I missed out ","listText":"Wow, I missed out ","text":"Wow, I missed out","images":[{"img":"https://static.tigerbbs.com/e550d8b50d345c5b2b473e556efd3a6e","width":"1125","height":"3060"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/818351914","isVote":1,"tweetType":1,"viewCount":1939,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":830562322,"gmtCreate":1629082133666,"gmtModify":1633687535941,"author":{"id":"3577092916321492","authorId":"3577092916321492","name":"Chengstacy","avatar":"https://static.tigerbbs.com/d46f3f41d17cb95ee8d8a9e817e22983","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577092916321492","idStr":"3577092916321492"},"themes":[],"title":"","htmlText":"Can consider this? ","listText":"Can consider this? ","text":"Can consider this?","images":[{"img":"https://static.tigerbbs.com/f0c624a61dde8c5ac831a14f1624d1bf","width":"1125","height":"2321"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/830562322","isVote":1,"tweetType":1,"viewCount":1685,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":890127046,"gmtCreate":1628087809985,"gmtModify":1631883983440,"author":{"id":"3577092916321492","authorId":"3577092916321492","name":"Chengstacy","avatar":"https://static.tigerbbs.com/d46f3f41d17cb95ee8d8a9e817e22983","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577092916321492","idStr":"3577092916321492"},"themes":[],"title":"","htmlText":"Just continue moving on…","listText":"Just continue moving on…","text":"Just continue moving on…","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/890127046","repostId":"1199044074","repostType":4,"isVote":1,"tweetType":1,"viewCount":3415,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":false}